Surgery
Showing 151-160 of 207 Results
-
Carla Pugh, MD, PhD
Thomas Krummel Professor
Current Research and Scholarly InterestsThe Technology Enabled Clinical Improvement (T.E.C.I.) Center is a multidisciplinary team of researchers dedicated to the design and implementation of advanced engineering technologies that facilitate data acquisition relating to clinical performance.
-
Benjamin Micah Raber
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Benjamin Raber is a board-certified, fellowship-trained surgical oncologist at Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Raber specializes in surgical treatments for benign and cancerous breast diseases. He performs a wide range of procedures, including lumpectomy, nipple-sparing mastectomy, and preventive mastectomy. Dr. Raber uses the latest and most effective surgical approaches, including wire-free, breast-conserving surgery for lumpectomies and hidden scar surgery (to hide incisions). He is committed to compassionate, patient-centered care that involves close collaboration with his colleagues in medical and radiation oncology, radiology, and plastic surgery.
Dr. Raber is actively involved in community outreach and breast cancer education. He has led regional initiatives to promote awareness, expand access to breast cancer screenings, and improve early detection.
Dr. Raber’s research focuses on improving surgical treatments for breast cancer, including better ways to treat cancer that has spread to nearby lymph nodes. He has also explored using ultrasound imaging to help surgeons locate and remove cancerous tissue more precisely during breast-conserving surgery. His research has been published in prominent peer-reviewed journals, including Annals of Surgical Oncology, Magnetic Resonance Imaging Clinics of North America, and The American Journal of Surgery.
Dr. Raber is a fellow of the American College of Surgeons (ACS) and a member of the American Society of Breast Surgeons (ASBrS). -
Gary K. Roberts, D.D.S.
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Roberts has performed hospital dentistry and surgery at Stanford University Medical Center and Lucile Packard Children's Hospital since 1995. He is also on the faculty at University of the Pacific School of Dentistry. He treats a variety of oral and maxillofacial conditions, including dental trauma and infection, dental implant and restorative reconstruction, surgical tooth extraction, bone and tissue grafting, conventional and surgical endodontic procedures, dental oncology care of cancer patients, as well as orofacial pain treatment.
He has presented CME lectures and Grand Rounds to numerous Departments at Stanford, as well as teaching Residents and Fellows at Stanford Medical School and the Palo Alto VA. He also lectures in the Physician Assistant Program at Stanford.
During his nearly a quarter of a century of military service, he was one of the leading researchers on combat trauma and the pathophysiology of projectile wounds. He currently serves as a member of the Council on Peer with the California Dental Association and is an Anesthesia Evaluator for the California State Dental Board. Dr. Roberts is frequently asked to speak on a variety of topics to organizations both in the US and internationally. -
Brian Ruhle, MD, MS
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Brian Ruhle is a board-certified surgeon with dual-fellowship training in minimally invasive bariatric (weight loss) surgery and endocrine surgery. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Ruhle specializes in bariatric surgery, foregut (upper digestive tract) surgery, adrenal surgery, and abdominal wall reconstruction. He uses leading-edge laparoscopic and robotic surgical techniques to help patients achieve sustainable weight loss and improve obesity-related health conditions. His expertise in advanced minimally invasive procedures offers patients significant benefits, including faster recoveries, reduced pain, and shorter hospital stays.
Dr. Ruhle’s research interests span a wide range of topics in metabolic and bariatric surgery. His studies have explored combination therapies for managing obesity, improvements in screening and treating endocrine disorders, and optimizing outcomes in thyroid and parathyroid surgeries. He has published his findings in many peer-reviewed journals, including Surgery, Journal of Gastrointestinal Surgery, and Journal of the American College of Surgeons.
Dr. Ruhle has presented at prominent national conferences, including the annual meetings of the American Association of Endocrine Surgeons and the American College of Surgeons Clinical Congress. His presentations have discussed using GLP-1 receptor agonists (weight loss medications that help regulate blood sugar and reduce appetite) before and after bariatric surgery. He has also addressed improving screening protocols for hyperaldosteronism (high blood pressure caused by excess production of the hormone aldosterone by the adrenal gland).
Dr. Ruhle is a member of the American Association of Endocrine Surgeons, the American Society for Metabolic and Bariatric Surgery, and the Society of American Gastrointestinal and Endoscopic Surgeons. -
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.
Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology.
